Bacterial Outer Membrane Vesicle Based Versatile Nanosystem Boosts the Efferocytosis Blockade Triggered Tumor-Specific Immunity

Efferocytosis inhibition is emerging as an attractive strategy for antitumor immune therapy because of the subsequent leak of abundant immunogenic contents. However, the practical efficacy is seriously impeded by the immunosuppressive tumor microenvironments. Here, we construct a versatile nanosystem that can not only inhibit the efferocytosis but also boost the following antitumor immunity. UNC2025 is loaded into the bacterial outer membrane vesicles (OMVs), which are then modified with maleimide (Mal). The prepared mU@OMVs effectively inhibits the efferocytosis by promoting the uptake while preventing the MerTK phosphorylation of tumor associated macrophages, and then captures the released TAAs through forming universal thioether bonds. The obtained in situ vaccine effectively transfers to LNs with by virtue of the intrinsic features of OMVs, and then provokes intense immune responses that can efficiently prevent the growth, metastasis and recurrence of tumors in mice, providing a novel strategy for cancer immunotherapy.